about
The Novel Antitubulin Agent TR-764 Strongly Reduces Tumor Vasculature and Inhibits HIF-1α Activation.Long-Pentraxin 3 Derivative as a Small-Molecule FGF Trap for Cancer TherapyLong pentraxin 3/tumor necrosis factor-stimulated gene-6 interaction: a biological rheostat for fibroblast growth factor 2-mediated angiogenesisSynthesis and Biological Evaluation of 2-Methyl-4,5-Disubstituted Oxazoles as a Novel Class of Highly Potent Antitubulin Agents.Antiangiogenic activity of a neutralizing human single-chain antibody fragment against fibroblast growth factor receptor 1.Phage displayed peptides/antibodies recognizing growth factors and their tyrosine kinase receptors as tools for anti-cancer therapeutics.Design, synthesis, in vitro, and in vivo anticancer and antiangiogenic activity of novel 3-arylaminobenzofuran derivatives targeting the colchicine site on tubulin.The broad-spectrum anti-DNA virus agent cidofovir inhibits lung metastasis of virus-independent, FGF2-driven tumors.Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis.A long pentraxin-3-derived pentapeptide for the therapy of FGF8b-driven steroid hormone-regulated cancers.Synthesis, Structural Elucidation, and Biological Evaluation of NSC12, an Orally Available Fibroblast Growth Factor (FGF) Ligand Trap for the Treatment of FGF-Dependent Lung Tumors.Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis.Design and Synthesis of Potent in Vitro and in Vivo Anticancer Agents Based on 1-(3',4',5'-Trimethoxyphenyl)-2-Aryl-1H-ImidazoleInhibition of angiogenesis by β-galactosylceramidase deficiency in globoid cell leukodystrophy.Monomeric gremlin is a novel vascular endothelial growth factor receptor-2 antagonist.Inflammatory cells and chemokines sustain FGF2-induced angiogenesis.Delivering cytokines at tumor site: The immunocytokine-conjugated anti-EDB-fibronectin antibody case.The potential of fibroblast growth factor/fibroblast growth factor receptor signaling as a therapeutic target in tumor angiogenesis.U94 of human herpesvirus 6 down-modulates Src, promotes a partial mesenchymal-to-epithelial transition and inhibits tumor cell growth, invasion and metastasis.Vascular disrupting activity of combretastatin analogues.Blocking the FGF/FGFR system as a "two-compartment" antiangiogenic/antitumor approach in cancer therapy.HDAC7 inhibition resets STAT3 tumorigenic activity in human glioblastoma independently of EGFR and PTEN: new opportunities for selected targeted therapies.Cavin-1 and Caveolin-1 are both required to support cell proliferation, migration and anchorage-independent cell growth in rhabdomyosarcoma.Long pentraxin-3 as an epithelial-stromal fibroblast growth factor-targeting inhibitor in prostate cancer.Fibroblast growth factors (FGFs) in cancer: FGF traps as a new therapeutic approach.Tumor angiogenesis revisited: Regulators and clinical implications.Long pentraxin-3 inhibits FGF8b-dependent angiogenesis and growth of steroid hormone-regulated tumors.Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists.Gene expression profile in fibroblast growth factor 2-transformed endothelial cells.Fibroblast growth factor receptor-1 phosphorylation requirement for cardiomyocyte differentiation in murine embryonic stem cells.Impact of VEGF-dependent tumour micro-environment on EDB fibronectin expression by subcutaneous human tumour xenografts in nude mice.Fibroblast growth factor receptor-1 is essential for in vitro cardiomyocyte development.Long pentraxin-3 inhibits epithelial-mesenchymal transition in melanoma cells.Fibroblast growth factor modulates mast cell recruitment in a murine model of prostate cancer.Fibroblast growth factor receptor-1 expression is required for hematopoietic but not endothelial cell development.Inflammation and N-formyl peptide receptors mediate the angiogenic activity of human vitreous humour in proliferative diabetic retinopathy.Molecular cloning and knockdown of galactocerebrosidase in zebrafish: new insights into the pathogenesis of Krabbe's disease.Long pentraxin 3: A novel multifaceted player in cancer.Contribution of vascular endothelial growth factor receptor-2 sialylation to the process of angiogenesis.Paracrine interactions of cancer-associated fibroblasts, macrophages and endothelial cells: tumor allies and foes.
P50
Q27341833-A9948BA0-E2E5-404C-89BC-4705D53541CFQ28115288-BA754B29-D7A1-4D3B-BD8D-63E46DEBA374Q28118263-257960A1-F395-4D36-B130-A57D7A978530Q33560133-72A62457-79F8-48C9-B7C8-DF503739C562Q33715953-4955AD0E-5C23-4707-8D5A-417F444E8FDDQ34273411-EF1BB38A-A413-4447-A87E-8485DA9BAABDQ35532093-F929FCF3-E09B-4204-84FE-1F7CA5C4FFE9Q35741522-59E16F46-5979-4119-84B6-17303996897AQ35791487-1E0A5A2A-0332-4B2B-A0BD-AB1F7DD566ECQ35955446-E660EAD5-3B92-497C-A992-885DC3C172ACQ36006477-50D29EC2-8955-45A6-982C-A778E2F98643Q36111400-83B445BC-7941-4F4C-8B0F-BF2A0FC327BDQ36928505-6DDAB522-8351-4930-889B-60CAFDB91EF5Q37124501-0893AF83-C8B1-40B8-8CED-1ED34F3AF032Q37376551-DA8F1E75-D445-47AE-B749-6E098AA6623DQ37525703-4C898234-016B-4A7A-8283-B69353CFEA42Q37558829-8E0C18AA-D040-4BB3-BE0E-A0534F0D9824Q38540713-2BD85EDA-C60A-48CE-B6F4-1DF55FF77807Q38701732-EFFE213D-5AB7-4480-ADE3-C434CBD19F4CQ38767839-08D5DA67-4547-49E5-9E70-03B47CF48977Q38788203-6D4E4BE8-4041-4AB8-BAAB-9E5BE4D98AD6Q38795844-BCCC2B50-6AAF-421D-8D95-F996765AE9D3Q38893243-C0FF991B-CE3C-46AE-90F5-85992C05C674Q39191673-B44DDC64-0EAB-4467-AB47-7EAFB45219EFQ39341660-F92C07DD-F66F-4370-94F2-375B9B82CEE6Q39393740-A8FCB38D-34E3-4426-AF8A-D72F7D9ECBD4Q39505438-9EBF950F-E56D-4BE1-8E8B-34DAC78C5BDEQ40498531-C73FD705-F6EB-4373-B0A3-E3DA8C529E4EQ40738783-31D2C7D9-A521-4127-9CDA-35BD7A8006A6Q41850444-665FEA3F-D670-4C5C-94F1-E08C8D4812D2Q43262741-D2A5AD22-97D7-42FC-BB94-065F2761EBC6Q44534256-8E645943-19E1-4158-BC8A-7CF6625BF769Q45756180-6EC7C180-F5B8-4BD4-B0E8-EF3170474C29Q45857609-97364135-918D-4D28-B8E7-DE33FA8DD403Q46387652-A4FEFD3E-4A7B-4826-858B-FEDBC68A1044Q46433119-E08F8847-8224-4C97-B39F-3AA097D88D7DQ47073227-4E087BA2-1669-489F-8C81-B0DA8D6B1246Q47413775-4FF2A8EA-6E8B-4CAD-81A6-7E37D4AFCDE2Q47983641-74E43D1F-3FA9-4561-BF5D-68DD1D6DBF14Q51769574-6344B8A2-42B1-4E1C-B092-48079957E911
P50
description
researcher ORCID ID = 0000-0001-8979-7068
@en
wetenschapper
@nl
name
Roberto Ronca
@ast
Roberto Ronca
@en
Roberto Ronca
@es
Roberto Ronca
@nl
type
label
Roberto Ronca
@ast
Roberto Ronca
@en
Roberto Ronca
@es
Roberto Ronca
@nl
prefLabel
Roberto Ronca
@ast
Roberto Ronca
@en
Roberto Ronca
@es
Roberto Ronca
@nl
P106
P1153
6506326286
P21
P31
P496
0000-0001-8979-7068